Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Low Grade Serous Ovarian Cancer × 1 year × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 231 Carcinoma, Non-Small-Cell Lung 196 Prostatic Neoplasms 105 Neoplasms 91 Multiple Myeloma 76 Colorectal Neoplasms 65 Neoplasm Metastasis 64 Parkinson Disease 4, Autosomal Dominant Lewy Body 61 Lung Neoplasms 61 Ovarian Neoplasms 50 Melanoma 47 Leukemia, Myeloid, Acute 47 Carcinoma, Renal Cell 41 Carcinoma, Hepatocellular 41 Stomach Neoplasms 39 Squamous Cell Carcinoma of Head and Neck 37 Brain Neoplasms 37 Recurrence 36 Leukemia, Lymphocytic, Chronic, B-Cell 36 Triple Negative Breast Neoplasms 35 Urinary Bladder Neoplasms 34 Lymphoma, Follicular 34 Myasthenia Gravis 33 Colonic Neoplasms 33 Head and Neck Neoplasms 31 Small Cell Lung Carcinoma 28 Rectal Neoplasms 28 Pancreatic Neoplasms 28 Nasopharyngeal Carcinoma 27 Lymphoma, Non-Hodgkin 26

Interventions

liposomal doxorubicin 1 defactinib 1 Paclitaxel 1 Letrozole 1 Anastrozole 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06072781 2026-03-17

RAMP 301

Verastem, Inc.

Phase 3 Recruiting

Low Grade Serous Ovarian Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡